DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Emcure Pharmaceuticals Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·12 Oct 2026, 7:36 am

Emcure Pharmaceuticals

Emcure Pharmaceuticals Limited has informed stock exchanges that it has received a certificate under SEBI’s Depositories and Participants Regulations, 2018. This regulatory filing confirms that the company has complied with the necessary requirements for its securities to be held in electronic form through depositories.

This development is a routine administrative update that validates the company's adherence to market infrastructure rules. For investors, it confirms the smooth functioning of the dematerialization process for Emcure shares, ensuring that the company's equity is tradable and settled efficiently through the depository system.

Investors should monitor the stock for any broader market reactions to this regulatory compliance. While this specific filing is generally non-material, it reinforces the company's adherence to corporate governance standards. Continued focus on the company's quarterly performance and pipeline will be key for assessing its future growth trajectory.